DiscoverAxios Re:CapThe year psychedelics went mainstream
The year psychedelics went mainstream

The year psychedelics went mainstream

Update: 2021-12-211
Share

Description

Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022.

Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major research trend that flew under the radar this year: increased public and private funding for trials looking into therapeutic psychedelics.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The year psychedelics went mainstream

The year psychedelics went mainstream

Axios